Advertisement

Chromatographia

, Volume 28, Issue 5–6, pp 307–310 | Cite as

A specific sensitive HPLC method for determination of plasma dopamine

  • Parinam S. Rao
  • Nisa Rujikarn
  • J. M. LuberJr.
  • D. H. Tyras
Originals

Summary

We describe here a sensitive, selective and rapid method to quantitate plasma catecholamines, especially dopamine, using high-performance liquid chromatography with electrochemical detection. This method requires a 10-minute run time and has a threshold for detection of 2 picograms, (10pg/ml).

A number of commonly employed mobile phases for catecholamine analysis have been tested and have failed to detect dopamine in biological samples. Neither acetonitrile (3–7%) or methanol, (5–8%) in the mobile phase has produced consistently interpretable data either due to inability to detect or interference from co-eluting substances. Optimal detection was achieved with a mobile phase containing sodium acetate (6.8g), citric acid (5.9g), EDTA (48mg), di-n-butylamine (270μl), Na-1-octane sulfate (850mg), methanol (100 ml) (amounts refer to 1 liter aqueous solution) (pH 4.3). The mobile phase was passed through a Waters 5μ resolve C18 column using a Waters 590 pump and m460 electrochemical detector and 740 data module, Flow rate was 0.9ml/min. Using this method, normal values in human and swine left ventricular myocardium and human and swine plasma have been established for norepinephrine, epinephrine, and dopamine.

Key Words

Column liquid chromatography Plasma Catecholamines Dopamine Electrochemical detection 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    G. C. Davis, P. T. Kissinger, R. E. Shoup, Anal. Chem.53, 156 (1981).Google Scholar
  2. [2]
    P. Hjemdahl, Am. J. Physiol.,257, E 13 (1984).Google Scholar
  3. [3]
    D. S. Goldstein, R. Stull, S. P. Markey, E. S. Marks, H. R. Keiser, J. Chromatogr.,311, 148 (1984).Google Scholar
  4. [4]
    W. R. Matson, P. Langlais, L. Volicer, P. H. Camache, E. Bird, K. A. Kirk, Clin. Chem.30, 1477 (1984).Google Scholar
  5. [5]
    D. S. Goldstein, G. Z. Feuerstei, J. L. Izzo Jr., I. J. Kopin, H. R. Keiser, Life Sci.28, 467 (1981).Google Scholar
  6. [6]
    O. Kuchel, N. T. Buu, A. Fontaine, P. Hamet, V. Beroniade, P. Larochelle, J. Genest, Hypertension2, 177 (1980).Google Scholar
  7. [7]
    P. S. Rao, J. M. Luber, Jr., Clin. Chem.32, A1167 (1986).Google Scholar
  8. [8]
    A. H. Anton, D. F. Sayre, J. Pharmacol. Exp. Ther.138, 360 (1962).Google Scholar
  9. [9]
    H. Hallman, L. O. Farnebo, B. Hamberger, G. Jonsson, Life Sci.23, 1079 (1978)Google Scholar
  10. [10]
    H. Weicker, M. Feraudi, H. Hagele, R. Pluto, Clin. Chem. Acta.141, 17 (1984).Google Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1989

Authors and Affiliations

  • Parinam S. Rao
    • 1
  • Nisa Rujikarn
    • 1
  • J. M. LuberJr.
    • 1
  • D. H. Tyras
    • 1
  1. 1.Division of Cardiothoracic SurgeryLong Island Jewish Medical CenterNew Hyde ParkUSA

Personalised recommendations